The fact
This measure aims to accelerate pharmaceutical innovation in the United States.
Critics fear it could hinder medical progress by limiting access to generics.
Click the link to read an article on the topic:
This measure aims to accelerate pharmaceutical innovation in the United States.
Critics fear it could hinder medical progress by limiting access to generics.